UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of
1934
Vringo, Inc.
(Name of Issuer)
Common Stock, par value $0.01 per
share
(Title of Class of Securities)
92911N104
(CUSIP Number)
May 4, 2015
(Date of Event Which Requires Filing
of this Statement)
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
a. |
o |
Rule 13d-1(b) |
|
|
|
b. |
x |
Rule 13d-1(c) |
|
|
|
c. |
o |
Rule 13d-1(d) |
* |
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page
shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
(1) |
|
Names
of
reporting
persons.
I.R.S. Identification Nos. of above persons
(entities only)
Iroquois Capital Management L.L.C.
|
(2) |
|
Check
the appropriate
box if a member
of a group
(see instructions)
(a) o
(b) o
|
(3) |
|
SEC
use only
|
(4) |
|
Citizenship
or place of
organization
Delaware
|
Number of
shares
beneficially
owned by
each
reporting
person
with: |
|
(5) |
|
Sole
voting power
0
|
|
|
(6) |
|
Shared
voting power
Convertible Notes convertible into 12,500,000 shares of common
stock
Warrants to purchase 2,219,803 shares of common stock (see Item 4)
|
|
|
(7) |
|
Sole
dispositive power
0
|
|
|
(8) |
|
Shared
dispositive power
Convertible Notes convertible into 12,500,000 shares of
common stock
Warrants to purchase 2,219,803 shares of common stock (see Item 4)
|
(9) |
|
Aggregate
amount
beneficially
owned
by
each
reporting
person
Convertible Notes convertible into 12,500,000
shares of common stock
Warrants to purchase 2,219,803 shares of common stock (see Item 4)
|
(10) |
|
Check
if the aggregate amount in
Row (9) excludes certain shares
(see instructions)
|
(11) |
|
Percent
of class represented by amount
in Row (9)
9.9% (see Item 4)*
|
(12) |
|
Type
of reporting person (see instructions)
OO
|
* The Convertible Notes may not be converted, and the warrants
are not exercisable, to the extent that the holder or any of its affiliates would own more than a maximum of 9.99% of the outstanding
common stock of the Issuer after such conversion or exercise. The securities reported in rows (6), (8) and (9) show the number
of shares of common stock that would be issuable upon full conversion of the Convertible Notes, and full exercise of the warrants,
and do not give effect to the foregoing limitations. Therefore, the actual number of shares of common stock beneficially
owned by the reporting person, after giving effect to these limitations, is less than the number of securities reported in rows
(6), (8) and (9).
(1) |
|
Names of reporting persons.
I.R.S. Identification Nos. of above
persons (entities only)
Joshua Silverman
|
(2) |
|
Check the appropriate box
if a member of a group (see instructions)
(a) o
(b) o
|
(3) |
|
SEC use only
|
(4) |
|
Citizenship or place of
organization
United States of America
|
Number of
shares
beneficially
owned by
each
reporting
person
with: |
|
(5) |
|
Sole
voting power
0
|
|
|
(6) |
|
Shared
voting power
Convertible Notes convertible into 12,500,000
shares of common stock
Warrants to purchase 2,219,803 shares of common stock (see Item 4)
|
|
|
(7) |
|
Sole
dispositive power
0
|
|
|
(8) |
|
Shared
dispositive power
Convertible Notes convertible into 12,500,000
shares of common stock
Warrants to purchase 2,219,803 shares of common stock (see Item 4)
|
(9) |
|
Aggregate amount beneficially owned by each
reporting person
Convertible Notes convertible into 12,500,000
shares of common stock
Warrants to purchase 2,219,803 shares of common stock (see Item 4)
|
(10) |
|
Check if the aggregate amount in Row (9) excludes
certain shares (see instructions)
|
(11) |
|
Percent of class represented by amount in
Row (9)
9.9% (see Item 4)
|
(12) |
|
Type of reporting person (see instructions)
IN; HC
|
* The Convertible Notes may not be converted, and the warrants
are not exercisable, to the extent that the holder or any of its affiliates would own more than a maximum of 9.99% of the outstanding
common stock of the Issuer after such conversion or exercise. The securities reported in rows (6), (8) and (9) show the number
of shares of common stock that would be issuable upon full conversion of the Convertible Notes, and full exercise of the warrants,
and do not give effect to the foregoing limitations. Therefore, the actual number of shares of common stock beneficially
owned by the reporting person, after giving effect to these limitations, is less than the number of securities reported in rows
(6), (8) and (9).
(1) |
|
Names of reporting persons.
I.R.S. Identification Nos. of above persons (entities
only)
Richard Abbe
|
(2) |
|
Check the appropriate box if a member of a
group (see instructions)
(a) o
(b) o
|
(3) |
|
SEC use only
|
(4) |
|
Citizenship or place of organization
United States of America
|
Number of
shares
beneficially
owned by
each
reporting
person
with: |
|
(5) |
|
Sole voting power
0
|
|
|
(6) |
|
Shared voting power
Convertible Notes convertible into 12,500,000
shares of common stock
Warrants to purchase 2,219,803 shares of common stock (see Item 4)
|
|
|
(7) |
|
Sole dispositive power
0
|
|
|
(8) |
|
Shared dispositive power
Convertible Notes convertible into 12,500,000
shares of common stock
Warrants to purchase 2,219,803 shares of common stock (see Item 4)
|
(9) |
|
Aggregate amount beneficially owned by each
reporting person
Convertible Notes convertible into 12,500,000
shares of common stock
Warrants to purchase 2,219,803 shares of common stock (see Item 4)
|
(10) |
|
Check if the aggregate amount in Row (9) excludes
certain shares (see instructions)
|
(11) |
|
Percent of class represented by amount in
Row (9)
9.9% (see Item 4)
|
(12) |
|
Type of reporting person (see instructions)
IN; HC
|
* The Convertible Notes may not be converted, and the warrants
are not exercisable, to the extent that the holder or any of its affiliates would own more than a maximum of 9.99% of the outstanding
common stock of the Issuer after such conversion or exercise. The securities reported in rows (6), (8) and (9) show the number
of shares of common stock that would be issuable upon full conversion of the Convertible Notes, and full exercise of the warrants,
and do not give effect to the foregoing limitations. Therefore, the actual number of shares of common stock beneficially
owned by the reporting person, after giving effect to these limitations, is less than the number of securities reported in rows
(6), (8) and (9).
Item 1.
(a) Name of Issuer
|
Vringo, Inc. (the “Issuer”) |
(b) Address of Issuer’s Principal Executive Offices
|
780 Third Avenue, 12th Floor
New York, NY 10017
|
Item 2.
(a) Name of Person Filing
(b) Address of Principal Business Office or, if none, Residence
(c) Citizenship
|
This Schedule 13G is being filed on behalf of (i) Iroquois Capital Management
L.L.C., a Delaware limited liability company (“Iroquois”), (ii) Joshua Silverman, an individual who is a citizen
of the United States of America (“Mr. Silverman”) and (iii) Richard Abbe, an individual who is a citizen of the
United States of America (“Mr. Abbe,” together with Iroquois and Mr. Silverman, the “Reporting Persons”). |
|
|
|
The Reporting Persons have entered into a Joint Filing Agreement, a copy
of which is filed with this Schedule 13G as Exhibit 1, pursuant to which the Reporting Persons have agreed to file this Schedule
13G jointly in accordance with the provisions of Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended. |
|
|
|
The principal business office of all of the Reporting Persons is 205
East 42nd St- 20th Fl., New York NY 10017. |
(d) Title of Class of Securities
|
Common stock, par value $0.01 per share, of the Issuer (the “Common
Stock”). |
(e) CUSIP Number
Item 3. |
If this statement is filed pursuant to §§
240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: |
|
|
|
Not applicable. |
|
|
|
(a) |
o |
Broker or dealer registered under section 15
of the Act (15 U.S.C. 78o); |
|
|
|
|
|
(b) |
o |
Bank as defined in section 3(a)(6) of the Act (15 U.S.C.
78c); |
|
|
|
|
|
(c) |
o |
Insurance company as defined in section 3(a)(19) of the
Act (15 U.S.C. 78c); |
|
|
|
|
|
(d) |
o |
Investment company registered under
Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); |
|
|
|
|
|
(e) |
o |
An investment adviser in accordance
with § 240.13d-1(b)(1)(ii)(E); |
|
|
|
|
|
(f) |
o |
An employee benefit plan or endowment
fund in accordance with § 240.13d-1(b)(1)(ii)(F); |
|
|
|
|
|
(g) |
o |
A parent holding company or control
person in accordance with § 240.13d-1(b)(1)(ii)(G); |
|
|
|
|
|
(h) |
o |
A savings association as defined in
Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); |
|
|
|
|
|
(i) |
o |
A church plan that is excluded from
the definition of an investment company under section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3); |
|
|
|
|
|
(j) |
o |
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J); |
|
|
|
|
|
(k) |
o |
Group, in accordance with § 240.13d-1(b)(1)(ii)(K). |
|
|
|
|
|
If filing as a non-U.S. institution in accordance
with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:______________________________________________________________ |
Item 4. Ownership.
(a) and (b):
As of the date of this filing, each of the
Reporting Persons may deemed to beneficially own (i) $12,500,000 principal amount of Senior Secured Convertible Notes (the
“Convertible Notes”) convertible into 12,500,000 shares of common stock of the Issuer, and (ii) warrants (the
“Warrants”) to purchase an aggregate of 2,219,803 shares of common stock of the Issuer. Of such shares,
10,000,000 shares of common stock are issuable upon Convertible Notes held by Iroquois Master Fund Ltd. (the
“Fund”), and 2,500,000 shares of common stock are issuable upon Convertible Notes held by Iroquois Capital
Investment Group LLC (“ICIG”). The Warrants are all held by the Fund. The foregoing amount of shares issuable
upon conversion of the Convertible Notes does not include any shares that the Issuer may elect to issue, at its option, to
the Fund and ICIG in payment of certain amounts due under the Convertible Notes. The Warrants described above expire on June
21, 2015. The number of shares issuable upon the Warrants set forth above does not include 5,375,000 shares of common stock
issuable upon exercise of Warrants that become exercisable beginning November 5, 2015. The Convertible Notes may not be
converted, and the Warrants are not exercisable, to the extent that the holder or any of its affiliates would own more than a
maximum of 9.99% of the outstanding common stock of the Issuer after such conversion or exercise.
Mr. Abbe and Mr. Silverman are the members of Iroquois
who have the authority and responsibility for the investments made on behalf of the Fund and ICIG. As such, Mr. Abbe and Mr. Silverman
may be deemed to be the beneficial owner of all shares of common stock held by the Fund and ICIG.
(c)(i) Number of shares as to which each
of the Reporting Persons has:
(i) Sole power to vote or to direct the vote: 0.
(ii) Shared power to vote or to direct the vote:
9.99% (as described in Item 4(a) above).
(iii) Sole power to dispose or to direct the disposition
of: 0.
(iv) Shared power to dispose or to direct the disposition
of: 9.99% (as described in Item 4(a) above).
Item 5. Ownership of Five Percent or Less of a Class
Item 6. Ownership of More than Five Percent on Behalf of
Another Person
Item 7. Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on By the Parent Holding Company
Item 8. Identification and Classification of Members of
the Group
Item 9. Notice of Dissolution of Group
Item 10. Certification
By signing below I certify that, to the
best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with
the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best
of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: May 12, 2015
IROQUOIS CAPITAL MANAGEMENT L.L.C. |
|
|
|
|
By: |
|
/s/ Joshua Silverman |
|
|
|
Joshua Silverman, Authorized Signatory |
|
|
|
/s/ Joshua Silverman |
|
Joshua Silverman |
|
|
|
/s/ Richard Abbe |
|
Richard Abbe |
|
EXHIBIT INDEX
Exhibit 1 | Joint Filing Agreement as required by Rule 13d-1(k)(1) under
the Securities Exchange Act of 1934, as amended. |
Exhibit 1
JOINT FILING AGREEMENT PURSUANT TO RULE
13d-1(k)(1)
The undersigned acknowledge and agree that the foregoing statement
on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule
13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing statements.
The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness
and accuracy of the information concerning him, her or it contained herein, but shall not be responsible for the completeness
and accuracy of the information concerning the other entities or persons, except to the extent that he, she or it knows or has
reason to believe that such information is inaccurate.
Date: May 12, 2015
|
IROQUOIS CAPITAL MANAGEMENT L.L.C. |
|
|
|
|
|
|
By: |
/s/ Joshua Silverman |
|
|
|
Joshua Silverman, Authorized Signatory |
|
|
|
|
|
|
/s/ Joshua Silverman |
|
|
Joshua Silverman |
|
|
|
|
|
|
/s/ Richard Abbe |
|
|
Richard Abbe |
|
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Mar 2024 to Apr 2024
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Apr 2023 to Apr 2024